Practical genetics: Alpha-1-antitrypsin deficiency and the serpinopathies

European Journal of Human Genetics

Volumn 12, Issue 3, 2004, Pages 167-172

  Crowther, Damian C ^a   Belorgey, Didier ^a   Miranda, Elena ^a   Kinghorn, Kerri J ^a   Sharp, Lynda K ^a   Lomas, David A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

1 antichymotrypsin; 1 antitrypsin; Antithrombin; C1 inhibitor; Neuroserpin; Serpinopathies; Serpins

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; BRONCHODILATING AGENT; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; MUTANT PROTEIN; OXYGEN; POLYMER; SERINE PROTEINASE INHIBITOR;

ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANGIONEUROTIC EDEMA; BRAIN DISEASE; CELL INCLUSION; CELL SECRETION; CLINICAL FEATURE; CONFORMATIONAL TRANSITION; DEMENTIA; DISEASE SEVERITY; GENE MUTATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; ISOELECTRIC FOCUSING; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MOLECULAR MECHANICS; MOUSE; NERVE CELL; NEWBORN HEPATITIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FAMILY; REVIEW; SMOKING CESSATION; THROMBOSIS;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; HUMANS; PROTEIN STRUCTURE, TERTIARY; SERINE PROTEINASE INHIBITORS;

EID: 1942450931     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201127     Document Type: Review

References (30)

1. 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280 kb region on chromosome 14q31.1. Am J Hum Genet 1993; 52: 343-353.
2. Brantly M, Nukiwa T, Crystal RG: Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988; 84 (Suppl 6A): 13-31.
3. Blanco I, Fernández E, Bustillo EF: Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet 2001; 60: 31-41.
4. 1-antitrypsin deficiency: a model for conformational diseases. N Engl J Med 2002; 346: 45-53.
5. Lomas DA, Carrell RW: Serpinopathies and the conformational dementias. Nat Rev Genet 2002; 3: 759-768.
6. Lomas DA, Mahadeva R: Alpha-1-antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002; 110: 1585-1590.
7. 1-antitrypsin accumulation in the liver. Nature 1992; 357: 605-607.
8. Janciauskiene S, Dominaitiene R, Sternby NH, Piitulainen E, Eriksson S: Detection of circulating and endothelial cell polymers of Z and wildtype alpha-1-antitrypsin by a monoclonal antibody. J Biol Chem 2002; 277: 26540-26546.
9. 1-antitrypsin is preferentially selected for degradation. Proc Natl Acad Sci USA 2003; 100: 8229-8234.
10. Piitulainen E, Eriksson S: Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency. Eur Resp J 1999; 13: 247-251.
11. 1-antitrypsin, and immunoglobulin E after adjustment for the effect of the Pi locus. Genet Epidemiol 1989; 7: 137-149.
12. 1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest 1987; 80: 1366-1374.
13. 1-antitrypsin related emphysema. Am J Resp Cell Mol Biol 1998; 18: 670-674.
14. 1-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Resp Cell Mol Biol 2002; 26: 723-730.
15. 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci 1987; 72: 373-381.
16. 1-antitrypsin deficient children. Acta Paediatr Scand 1988; 77: 847-851.
17. 1-antitrypsin deficiency. N Engl J Med 1986; 314: 736-739.
18. 1-antitrypsin augmentation therapy. Am J Resp Crit Care Med 1999; 160: 1468-1472.
19. 1-antitrypsin deficiency. Thorax 1998; 53: 265-268.
20. 1-antitrypsin: a transgenic mouse model. Science 1988; 242: 1409-1412.
21. 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest 1989; 83: 1183-1190.
22. Ali R, Perfumo S, della Rocca C et al: Evaluation of a transgenic mouse model for alpha-1-antitrypsin (AAT) related liver disease. Ann Hum Genet 1994; 58: 305-320.
23. Green C, Brown G, Dafforn TR, Morley T, Lomas DA, Gubb D: Mutations in the Drosophila serpin necrotic mirror disease-associated mutations of human serpins. Development 2003; 130: 1473-1478.
24. 1-antitrypsin. Am J Resp Crit Care Med 1998; 158: 49-59.
25. Ibarguen E, Gross CR, Savik SK, Sharp HL: Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. J Pediatr 1990; 117: 864-870.
26. Silverman GA, Bird PI, Carrell RW et al: The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, novel functions, mechanism of inhibition and a revised nomenclature. J Biol Chem 2001; 276: 33293-33296.
27. Davis RL, Shrimpton AE, Holohan PD et al: Familial dementia caused by polymerisation of mutant neuroserpin. Nature 1999; 401: 376-379.
28. Davis RL, Shrimpton AE, Carrell RW et al: Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet 2002; 359: 2242-2247.
29. Belorgey D, Crowther DC, Mahadeva R, Lomas DA: Mutant neuroserpin (Ser49Pro) that causes the familial dementia FENIB is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem 2002; 277: 17367-17373.
30. 1-antichymotrypsin indicates two stage insertion of the reactive loop; implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 2000; 97: 67-72.